Focus: Biolinq is a San Diego-based biotech company focused on needle-free blood glucose monitoring through wearable biowearable systems for diabetes management. The company operates in the medical device/diagnostic space within metabolic diseases.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Best suited for mission-driven professionals willing to accept early-stage biotech risk in exchange for equity upside and meaningful impact in diabetes care innovation.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Biolinq
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Biolinq's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo